UBS Group’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.67M | Buy |
|
|||||
|
2025
Q1 | $3.4M | Buy |
|
|||||
|
2024
Q4 | $3.84M | Buy |
|
|||||
|
2024
Q3 | $305K | Buy |
|
|||||
|
2024
Q2 | $125K | Buy |
|
|||||
|
2024
Q1 | $64.6K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $391 | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $14.6K | Sell |
|
|||||
|
2022
Q4 | $11.3K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $4K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $124K | Buy |
|
|||||
|
2021
Q3 | $100K | Buy |
|
|||||
|
2021
Q2 | $84K | Buy |
|